Baidu
map

Ann Thorac Surg:积极治疗早期肺癌可提高生存率

2018-01-05 佚名 肿瘤免疫细胞治疗资讯

加利福尼亚大学圣地亚哥分校医学院的研究人员表示,哪种方法更能改善生存方面的优越性还不清楚。以前的研究试图比较每个过程的病人结局,但结果却不尽相同。在这项研究中,研究人员进行了一种对早期肺癌的最大和最详细的分析。在4069例患者的研究中,多数行肺叶切除,16%例亚肺叶切除,11%接受SBRT。研究人员发现,治疗之后的五年,在切除组有23%患者死亡,采用放射治疗的患者45%死亡,亚肺叶切除患者的死亡率

加利福尼亚大学圣地亚哥分校医学院的研究人员表示,哪种方法更能改善生存方面的优越性还不清楚。以前的研究试图比较每个过程的病人结局,但结果却不尽相同。在这项研究中,研究人员进行了一种对早期肺癌的最大和最详细的分析。在4069例患者的研究中,多数行肺叶切除,16%例亚肺叶切除,11%接受SBRT。研究人员发现,治疗之后的五年,在切除组有23%患者死亡,采用放射治疗的患者45%死亡,亚肺叶切除患者的死亡率是32%。

根据2017年《胸外科年鉴》在线发表的一项研究,早期非小细胞肺癌的侵袭性手术比中等强度的手术和日益流行的放射治疗方法的存活时间更长。早期肺癌被定义为局限于肺部的一部分,没有扩散到肺部或身体的其他部位的癌症。从历史上看,肺叶切除,切除肿瘤的整个肺叶,是早期肺癌的首选治疗方法。但在过去的十年中,立体定向放射治疗(SBRT),精度破坏肿瘤,高剂量辐射两周的治疗方法已经变得越来越流行。

这些年来,肺叶切除术是一种越来越安全的常规手术,打开病人的胸腔,切除肿瘤的肺叶,一些外科医生采用微创技术切除肺叶,以减少切口。立体定向放射治疗不需要手术,可以在几天内完成。但最终,患者应该考虑哪种方法更可能治愈癌症呢?即使早期的肺癌也是一种危险的疾病,有很大的癌症复发风险。当观察病人的生存曲线时,并不是那么好。即使肺部只有一个结节,一些病人也会发展成晚期肺癌。因此,如果身体允许的话,研究人员还是建议手术治疗是生存希望最大的选择。

原始出处:

Bryant AK,et al.,Stereotactic Body Radiation Therapy Versus Surgery for Early Lung Cancer Among US Veterans.Ann Thorac Surg. 2017 Nov 21. pii: S0003-4975(17)31099-8.

版权声明:
本网站所有内容来源注明为“梅斯医学”或“MedSci原创”的文字、图片和音视频资料,版权均属于梅斯医学所有。非经授权,任何媒体、网站或个人不得转载,授权转载时须注明来源为“梅斯医学”。其它来源的文章系转载文章,或“梅斯号”自媒体发布的文章,仅系出于传递更多信息之目的,本站仅负责审核内容合规,其内容不代表本站立场,本站不负责内容的准确性和版权。如果存在侵权、或不希望被转载的媒体或个人可与我们联系,我们将立即进行删除处理。
在此留言
评论区 (62)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=2057019, encodeId=58ef205e019ad, content=<a href='/topic/show?id=a19b1e4042f' target=_blank style='color:#2F92EE;'>#THORAC#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=51, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=17404, encryptionId=a19b1e4042f, topicName=THORAC)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=052a130, createdName=yyj062, createdTime=Tue Jul 24 11:25:00 CST 2018, time=2018-07-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1666174, encodeId=7cb116661e404, content=<a href='/topic/show?id=5fd55943ecf' target=_blank style='color:#2F92EE;'>#早期肺癌#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=62, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=59437, encryptionId=5fd55943ecf, topicName=早期肺癌)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=592126038749, createdName=循证小兵, createdTime=Tue Apr 17 02:25:00 CST 2018, time=2018-04-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=293253, encodeId=03a0293253a7, content=同意比调查研究!受益匪浅!, beContent=null, objectType=article, channel=null, level=null, likeNumber=95, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2017/11/18/11084326017c92749e11fafe7cafb4fe.jpg, createdBy=aa662063559, createdName=1341ee7725m, createdTime=Mon Mar 05 14:51:16 CST 2018, time=2018-03-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=292121, encodeId=ea0729212155, content=好知识.值得学习, beContent=null, objectType=article, channel=null, level=null, likeNumber=100, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=59321624668, createdName=zb1235672, createdTime=Fri Mar 02 01:19:33 CST 2018, time=2018-03-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=291832, encodeId=9c29291832b7, content=好知识值得学习, beContent=null, objectType=article, channel=null, level=null, likeNumber=83, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=59321624668, createdName=zb1235672, createdTime=Thu Mar 01 01:45:21 CST 2018, time=2018-03-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=291501, encodeId=222e2915012f, content=好知识.值得学习, beContent=null, objectType=article, channel=null, level=null, likeNumber=68, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=59321624668, createdName=zb1235672, createdTime=Wed Feb 28 00:09:14 CST 2018, time=2018-02-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=290924, encodeId=26a2290924b7, content=好知识.值得学习, beContent=null, objectType=article, channel=null, level=null, likeNumber=85, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=59321624668, createdName=zb1235672, createdTime=Mon Feb 26 00:49:04 CST 2018, time=2018-02-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=290621, encodeId=21fe2906218b, content=好知识!值得学习, beContent=null, objectType=article, channel=null, level=null, likeNumber=48, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=59321624668, createdName=zb1235672, createdTime=Sun Feb 25 00:03:28 CST 2018, time=2018-02-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=290447, encodeId=4e1129044e10, content=好知识.值得学习, beContent=null, objectType=article, channel=null, level=null, likeNumber=53, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=59321624668, createdName=zb1235672, createdTime=Sat Feb 24 08:36:01 CST 2018, time=2018-02-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=290206, encodeId=833a29020692, content=好知识.值得学习, beContent=null, objectType=article, channel=null, level=null, likeNumber=53, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=59321624668, createdName=zb1235672, createdTime=Fri Feb 23 10:21:37 CST 2018, time=2018-02-23, status=1, ipAttribution=)]
    2018-07-24 yyj062
  2. [GetPortalCommentsPageByObjectIdResponse(id=2057019, encodeId=58ef205e019ad, content=<a href='/topic/show?id=a19b1e4042f' target=_blank style='color:#2F92EE;'>#THORAC#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=51, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=17404, encryptionId=a19b1e4042f, topicName=THORAC)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=052a130, createdName=yyj062, createdTime=Tue Jul 24 11:25:00 CST 2018, time=2018-07-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1666174, encodeId=7cb116661e404, content=<a href='/topic/show?id=5fd55943ecf' target=_blank style='color:#2F92EE;'>#早期肺癌#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=62, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=59437, encryptionId=5fd55943ecf, topicName=早期肺癌)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=592126038749, createdName=循证小兵, createdTime=Tue Apr 17 02:25:00 CST 2018, time=2018-04-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=293253, encodeId=03a0293253a7, content=同意比调查研究!受益匪浅!, beContent=null, objectType=article, channel=null, level=null, likeNumber=95, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2017/11/18/11084326017c92749e11fafe7cafb4fe.jpg, createdBy=aa662063559, createdName=1341ee7725m, createdTime=Mon Mar 05 14:51:16 CST 2018, time=2018-03-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=292121, encodeId=ea0729212155, content=好知识.值得学习, beContent=null, objectType=article, channel=null, level=null, likeNumber=100, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=59321624668, createdName=zb1235672, createdTime=Fri Mar 02 01:19:33 CST 2018, time=2018-03-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=291832, encodeId=9c29291832b7, content=好知识值得学习, beContent=null, objectType=article, channel=null, level=null, likeNumber=83, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=59321624668, createdName=zb1235672, createdTime=Thu Mar 01 01:45:21 CST 2018, time=2018-03-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=291501, encodeId=222e2915012f, content=好知识.值得学习, beContent=null, objectType=article, channel=null, level=null, likeNumber=68, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=59321624668, createdName=zb1235672, createdTime=Wed Feb 28 00:09:14 CST 2018, time=2018-02-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=290924, encodeId=26a2290924b7, content=好知识.值得学习, beContent=null, objectType=article, channel=null, level=null, likeNumber=85, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=59321624668, createdName=zb1235672, createdTime=Mon Feb 26 00:49:04 CST 2018, time=2018-02-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=290621, encodeId=21fe2906218b, content=好知识!值得学习, beContent=null, objectType=article, channel=null, level=null, likeNumber=48, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=59321624668, createdName=zb1235672, createdTime=Sun Feb 25 00:03:28 CST 2018, time=2018-02-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=290447, encodeId=4e1129044e10, content=好知识.值得学习, beContent=null, objectType=article, channel=null, level=null, likeNumber=53, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=59321624668, createdName=zb1235672, createdTime=Sat Feb 24 08:36:01 CST 2018, time=2018-02-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=290206, encodeId=833a29020692, content=好知识.值得学习, beContent=null, objectType=article, channel=null, level=null, likeNumber=53, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=59321624668, createdName=zb1235672, createdTime=Fri Feb 23 10:21:37 CST 2018, time=2018-02-23, status=1, ipAttribution=)]
  3. [GetPortalCommentsPageByObjectIdResponse(id=2057019, encodeId=58ef205e019ad, content=<a href='/topic/show?id=a19b1e4042f' target=_blank style='color:#2F92EE;'>#THORAC#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=51, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=17404, encryptionId=a19b1e4042f, topicName=THORAC)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=052a130, createdName=yyj062, createdTime=Tue Jul 24 11:25:00 CST 2018, time=2018-07-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1666174, encodeId=7cb116661e404, content=<a href='/topic/show?id=5fd55943ecf' target=_blank style='color:#2F92EE;'>#早期肺癌#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=62, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=59437, encryptionId=5fd55943ecf, topicName=早期肺癌)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=592126038749, createdName=循证小兵, createdTime=Tue Apr 17 02:25:00 CST 2018, time=2018-04-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=293253, encodeId=03a0293253a7, content=同意比调查研究!受益匪浅!, beContent=null, objectType=article, channel=null, level=null, likeNumber=95, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2017/11/18/11084326017c92749e11fafe7cafb4fe.jpg, createdBy=aa662063559, createdName=1341ee7725m, createdTime=Mon Mar 05 14:51:16 CST 2018, time=2018-03-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=292121, encodeId=ea0729212155, content=好知识.值得学习, beContent=null, objectType=article, channel=null, level=null, likeNumber=100, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=59321624668, createdName=zb1235672, createdTime=Fri Mar 02 01:19:33 CST 2018, time=2018-03-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=291832, encodeId=9c29291832b7, content=好知识值得学习, beContent=null, objectType=article, channel=null, level=null, likeNumber=83, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=59321624668, createdName=zb1235672, createdTime=Thu Mar 01 01:45:21 CST 2018, time=2018-03-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=291501, encodeId=222e2915012f, content=好知识.值得学习, beContent=null, objectType=article, channel=null, level=null, likeNumber=68, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=59321624668, createdName=zb1235672, createdTime=Wed Feb 28 00:09:14 CST 2018, time=2018-02-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=290924, encodeId=26a2290924b7, content=好知识.值得学习, beContent=null, objectType=article, channel=null, level=null, likeNumber=85, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=59321624668, createdName=zb1235672, createdTime=Mon Feb 26 00:49:04 CST 2018, time=2018-02-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=290621, encodeId=21fe2906218b, content=好知识!值得学习, beContent=null, objectType=article, channel=null, level=null, likeNumber=48, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=59321624668, createdName=zb1235672, createdTime=Sun Feb 25 00:03:28 CST 2018, time=2018-02-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=290447, encodeId=4e1129044e10, content=好知识.值得学习, beContent=null, objectType=article, channel=null, level=null, likeNumber=53, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=59321624668, createdName=zb1235672, createdTime=Sat Feb 24 08:36:01 CST 2018, time=2018-02-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=290206, encodeId=833a29020692, content=好知识.值得学习, beContent=null, objectType=article, channel=null, level=null, likeNumber=53, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=59321624668, createdName=zb1235672, createdTime=Fri Feb 23 10:21:37 CST 2018, time=2018-02-23, status=1, ipAttribution=)]
    2018-03-05 1341ee7725m

    同意比调查研究!受益匪浅!

    0

  4. [GetPortalCommentsPageByObjectIdResponse(id=2057019, encodeId=58ef205e019ad, content=<a href='/topic/show?id=a19b1e4042f' target=_blank style='color:#2F92EE;'>#THORAC#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=51, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=17404, encryptionId=a19b1e4042f, topicName=THORAC)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=052a130, createdName=yyj062, createdTime=Tue Jul 24 11:25:00 CST 2018, time=2018-07-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1666174, encodeId=7cb116661e404, content=<a href='/topic/show?id=5fd55943ecf' target=_blank style='color:#2F92EE;'>#早期肺癌#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=62, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=59437, encryptionId=5fd55943ecf, topicName=早期肺癌)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=592126038749, createdName=循证小兵, createdTime=Tue Apr 17 02:25:00 CST 2018, time=2018-04-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=293253, encodeId=03a0293253a7, content=同意比调查研究!受益匪浅!, beContent=null, objectType=article, channel=null, level=null, likeNumber=95, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2017/11/18/11084326017c92749e11fafe7cafb4fe.jpg, createdBy=aa662063559, createdName=1341ee7725m, createdTime=Mon Mar 05 14:51:16 CST 2018, time=2018-03-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=292121, encodeId=ea0729212155, content=好知识.值得学习, beContent=null, objectType=article, channel=null, level=null, likeNumber=100, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=59321624668, createdName=zb1235672, createdTime=Fri Mar 02 01:19:33 CST 2018, time=2018-03-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=291832, encodeId=9c29291832b7, content=好知识值得学习, beContent=null, objectType=article, channel=null, level=null, likeNumber=83, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=59321624668, createdName=zb1235672, createdTime=Thu Mar 01 01:45:21 CST 2018, time=2018-03-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=291501, encodeId=222e2915012f, content=好知识.值得学习, beContent=null, objectType=article, channel=null, level=null, likeNumber=68, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=59321624668, createdName=zb1235672, createdTime=Wed Feb 28 00:09:14 CST 2018, time=2018-02-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=290924, encodeId=26a2290924b7, content=好知识.值得学习, beContent=null, objectType=article, channel=null, level=null, likeNumber=85, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=59321624668, createdName=zb1235672, createdTime=Mon Feb 26 00:49:04 CST 2018, time=2018-02-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=290621, encodeId=21fe2906218b, content=好知识!值得学习, beContent=null, objectType=article, channel=null, level=null, likeNumber=48, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=59321624668, createdName=zb1235672, createdTime=Sun Feb 25 00:03:28 CST 2018, time=2018-02-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=290447, encodeId=4e1129044e10, content=好知识.值得学习, beContent=null, objectType=article, channel=null, level=null, likeNumber=53, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=59321624668, createdName=zb1235672, createdTime=Sat Feb 24 08:36:01 CST 2018, time=2018-02-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=290206, encodeId=833a29020692, content=好知识.值得学习, beContent=null, objectType=article, channel=null, level=null, likeNumber=53, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=59321624668, createdName=zb1235672, createdTime=Fri Feb 23 10:21:37 CST 2018, time=2018-02-23, status=1, ipAttribution=)]
    2018-03-02 zb1235672

    好知识.值得学习

    0

  5. [GetPortalCommentsPageByObjectIdResponse(id=2057019, encodeId=58ef205e019ad, content=<a href='/topic/show?id=a19b1e4042f' target=_blank style='color:#2F92EE;'>#THORAC#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=51, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=17404, encryptionId=a19b1e4042f, topicName=THORAC)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=052a130, createdName=yyj062, createdTime=Tue Jul 24 11:25:00 CST 2018, time=2018-07-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1666174, encodeId=7cb116661e404, content=<a href='/topic/show?id=5fd55943ecf' target=_blank style='color:#2F92EE;'>#早期肺癌#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=62, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=59437, encryptionId=5fd55943ecf, topicName=早期肺癌)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=592126038749, createdName=循证小兵, createdTime=Tue Apr 17 02:25:00 CST 2018, time=2018-04-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=293253, encodeId=03a0293253a7, content=同意比调查研究!受益匪浅!, beContent=null, objectType=article, channel=null, level=null, likeNumber=95, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2017/11/18/11084326017c92749e11fafe7cafb4fe.jpg, createdBy=aa662063559, createdName=1341ee7725m, createdTime=Mon Mar 05 14:51:16 CST 2018, time=2018-03-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=292121, encodeId=ea0729212155, content=好知识.值得学习, beContent=null, objectType=article, channel=null, level=null, likeNumber=100, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=59321624668, createdName=zb1235672, createdTime=Fri Mar 02 01:19:33 CST 2018, time=2018-03-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=291832, encodeId=9c29291832b7, content=好知识值得学习, beContent=null, objectType=article, channel=null, level=null, likeNumber=83, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=59321624668, createdName=zb1235672, createdTime=Thu Mar 01 01:45:21 CST 2018, time=2018-03-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=291501, encodeId=222e2915012f, content=好知识.值得学习, beContent=null, objectType=article, channel=null, level=null, likeNumber=68, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=59321624668, createdName=zb1235672, createdTime=Wed Feb 28 00:09:14 CST 2018, time=2018-02-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=290924, encodeId=26a2290924b7, content=好知识.值得学习, beContent=null, objectType=article, channel=null, level=null, likeNumber=85, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=59321624668, createdName=zb1235672, createdTime=Mon Feb 26 00:49:04 CST 2018, time=2018-02-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=290621, encodeId=21fe2906218b, content=好知识!值得学习, beContent=null, objectType=article, channel=null, level=null, likeNumber=48, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=59321624668, createdName=zb1235672, createdTime=Sun Feb 25 00:03:28 CST 2018, time=2018-02-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=290447, encodeId=4e1129044e10, content=好知识.值得学习, beContent=null, objectType=article, channel=null, level=null, likeNumber=53, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=59321624668, createdName=zb1235672, createdTime=Sat Feb 24 08:36:01 CST 2018, time=2018-02-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=290206, encodeId=833a29020692, content=好知识.值得学习, beContent=null, objectType=article, channel=null, level=null, likeNumber=53, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=59321624668, createdName=zb1235672, createdTime=Fri Feb 23 10:21:37 CST 2018, time=2018-02-23, status=1, ipAttribution=)]
    2018-03-01 zb1235672

    好知识值得学习

    0

  6. [GetPortalCommentsPageByObjectIdResponse(id=2057019, encodeId=58ef205e019ad, content=<a href='/topic/show?id=a19b1e4042f' target=_blank style='color:#2F92EE;'>#THORAC#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=51, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=17404, encryptionId=a19b1e4042f, topicName=THORAC)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=052a130, createdName=yyj062, createdTime=Tue Jul 24 11:25:00 CST 2018, time=2018-07-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1666174, encodeId=7cb116661e404, content=<a href='/topic/show?id=5fd55943ecf' target=_blank style='color:#2F92EE;'>#早期肺癌#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=62, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=59437, encryptionId=5fd55943ecf, topicName=早期肺癌)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=592126038749, createdName=循证小兵, createdTime=Tue Apr 17 02:25:00 CST 2018, time=2018-04-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=293253, encodeId=03a0293253a7, content=同意比调查研究!受益匪浅!, beContent=null, objectType=article, channel=null, level=null, likeNumber=95, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2017/11/18/11084326017c92749e11fafe7cafb4fe.jpg, createdBy=aa662063559, createdName=1341ee7725m, createdTime=Mon Mar 05 14:51:16 CST 2018, time=2018-03-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=292121, encodeId=ea0729212155, content=好知识.值得学习, beContent=null, objectType=article, channel=null, level=null, likeNumber=100, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=59321624668, createdName=zb1235672, createdTime=Fri Mar 02 01:19:33 CST 2018, time=2018-03-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=291832, encodeId=9c29291832b7, content=好知识值得学习, beContent=null, objectType=article, channel=null, level=null, likeNumber=83, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=59321624668, createdName=zb1235672, createdTime=Thu Mar 01 01:45:21 CST 2018, time=2018-03-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=291501, encodeId=222e2915012f, content=好知识.值得学习, beContent=null, objectType=article, channel=null, level=null, likeNumber=68, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=59321624668, createdName=zb1235672, createdTime=Wed Feb 28 00:09:14 CST 2018, time=2018-02-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=290924, encodeId=26a2290924b7, content=好知识.值得学习, beContent=null, objectType=article, channel=null, level=null, likeNumber=85, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=59321624668, createdName=zb1235672, createdTime=Mon Feb 26 00:49:04 CST 2018, time=2018-02-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=290621, encodeId=21fe2906218b, content=好知识!值得学习, beContent=null, objectType=article, channel=null, level=null, likeNumber=48, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=59321624668, createdName=zb1235672, createdTime=Sun Feb 25 00:03:28 CST 2018, time=2018-02-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=290447, encodeId=4e1129044e10, content=好知识.值得学习, beContent=null, objectType=article, channel=null, level=null, likeNumber=53, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=59321624668, createdName=zb1235672, createdTime=Sat Feb 24 08:36:01 CST 2018, time=2018-02-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=290206, encodeId=833a29020692, content=好知识.值得学习, beContent=null, objectType=article, channel=null, level=null, likeNumber=53, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=59321624668, createdName=zb1235672, createdTime=Fri Feb 23 10:21:37 CST 2018, time=2018-02-23, status=1, ipAttribution=)]
    2018-02-28 zb1235672

    好知识.值得学习

    0

  7. [GetPortalCommentsPageByObjectIdResponse(id=2057019, encodeId=58ef205e019ad, content=<a href='/topic/show?id=a19b1e4042f' target=_blank style='color:#2F92EE;'>#THORAC#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=51, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=17404, encryptionId=a19b1e4042f, topicName=THORAC)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=052a130, createdName=yyj062, createdTime=Tue Jul 24 11:25:00 CST 2018, time=2018-07-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1666174, encodeId=7cb116661e404, content=<a href='/topic/show?id=5fd55943ecf' target=_blank style='color:#2F92EE;'>#早期肺癌#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=62, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=59437, encryptionId=5fd55943ecf, topicName=早期肺癌)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=592126038749, createdName=循证小兵, createdTime=Tue Apr 17 02:25:00 CST 2018, time=2018-04-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=293253, encodeId=03a0293253a7, content=同意比调查研究!受益匪浅!, beContent=null, objectType=article, channel=null, level=null, likeNumber=95, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2017/11/18/11084326017c92749e11fafe7cafb4fe.jpg, createdBy=aa662063559, createdName=1341ee7725m, createdTime=Mon Mar 05 14:51:16 CST 2018, time=2018-03-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=292121, encodeId=ea0729212155, content=好知识.值得学习, beContent=null, objectType=article, channel=null, level=null, likeNumber=100, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=59321624668, createdName=zb1235672, createdTime=Fri Mar 02 01:19:33 CST 2018, time=2018-03-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=291832, encodeId=9c29291832b7, content=好知识值得学习, beContent=null, objectType=article, channel=null, level=null, likeNumber=83, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=59321624668, createdName=zb1235672, createdTime=Thu Mar 01 01:45:21 CST 2018, time=2018-03-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=291501, encodeId=222e2915012f, content=好知识.值得学习, beContent=null, objectType=article, channel=null, level=null, likeNumber=68, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=59321624668, createdName=zb1235672, createdTime=Wed Feb 28 00:09:14 CST 2018, time=2018-02-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=290924, encodeId=26a2290924b7, content=好知识.值得学习, beContent=null, objectType=article, channel=null, level=null, likeNumber=85, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=59321624668, createdName=zb1235672, createdTime=Mon Feb 26 00:49:04 CST 2018, time=2018-02-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=290621, encodeId=21fe2906218b, content=好知识!值得学习, beContent=null, objectType=article, channel=null, level=null, likeNumber=48, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=59321624668, createdName=zb1235672, createdTime=Sun Feb 25 00:03:28 CST 2018, time=2018-02-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=290447, encodeId=4e1129044e10, content=好知识.值得学习, beContent=null, objectType=article, channel=null, level=null, likeNumber=53, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=59321624668, createdName=zb1235672, createdTime=Sat Feb 24 08:36:01 CST 2018, time=2018-02-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=290206, encodeId=833a29020692, content=好知识.值得学习, beContent=null, objectType=article, channel=null, level=null, likeNumber=53, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=59321624668, createdName=zb1235672, createdTime=Fri Feb 23 10:21:37 CST 2018, time=2018-02-23, status=1, ipAttribution=)]
    2018-02-26 zb1235672

    好知识.值得学习

    0

  8. [GetPortalCommentsPageByObjectIdResponse(id=2057019, encodeId=58ef205e019ad, content=<a href='/topic/show?id=a19b1e4042f' target=_blank style='color:#2F92EE;'>#THORAC#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=51, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=17404, encryptionId=a19b1e4042f, topicName=THORAC)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=052a130, createdName=yyj062, createdTime=Tue Jul 24 11:25:00 CST 2018, time=2018-07-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1666174, encodeId=7cb116661e404, content=<a href='/topic/show?id=5fd55943ecf' target=_blank style='color:#2F92EE;'>#早期肺癌#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=62, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=59437, encryptionId=5fd55943ecf, topicName=早期肺癌)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=592126038749, createdName=循证小兵, createdTime=Tue Apr 17 02:25:00 CST 2018, time=2018-04-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=293253, encodeId=03a0293253a7, content=同意比调查研究!受益匪浅!, beContent=null, objectType=article, channel=null, level=null, likeNumber=95, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2017/11/18/11084326017c92749e11fafe7cafb4fe.jpg, createdBy=aa662063559, createdName=1341ee7725m, createdTime=Mon Mar 05 14:51:16 CST 2018, time=2018-03-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=292121, encodeId=ea0729212155, content=好知识.值得学习, beContent=null, objectType=article, channel=null, level=null, likeNumber=100, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=59321624668, createdName=zb1235672, createdTime=Fri Mar 02 01:19:33 CST 2018, time=2018-03-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=291832, encodeId=9c29291832b7, content=好知识值得学习, beContent=null, objectType=article, channel=null, level=null, likeNumber=83, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=59321624668, createdName=zb1235672, createdTime=Thu Mar 01 01:45:21 CST 2018, time=2018-03-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=291501, encodeId=222e2915012f, content=好知识.值得学习, beContent=null, objectType=article, channel=null, level=null, likeNumber=68, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=59321624668, createdName=zb1235672, createdTime=Wed Feb 28 00:09:14 CST 2018, time=2018-02-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=290924, encodeId=26a2290924b7, content=好知识.值得学习, beContent=null, objectType=article, channel=null, level=null, likeNumber=85, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=59321624668, createdName=zb1235672, createdTime=Mon Feb 26 00:49:04 CST 2018, time=2018-02-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=290621, encodeId=21fe2906218b, content=好知识!值得学习, beContent=null, objectType=article, channel=null, level=null, likeNumber=48, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=59321624668, createdName=zb1235672, createdTime=Sun Feb 25 00:03:28 CST 2018, time=2018-02-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=290447, encodeId=4e1129044e10, content=好知识.值得学习, beContent=null, objectType=article, channel=null, level=null, likeNumber=53, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=59321624668, createdName=zb1235672, createdTime=Sat Feb 24 08:36:01 CST 2018, time=2018-02-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=290206, encodeId=833a29020692, content=好知识.值得学习, beContent=null, objectType=article, channel=null, level=null, likeNumber=53, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=59321624668, createdName=zb1235672, createdTime=Fri Feb 23 10:21:37 CST 2018, time=2018-02-23, status=1, ipAttribution=)]
    2018-02-25 zb1235672

    好知识!值得学习

    0

  9. [GetPortalCommentsPageByObjectIdResponse(id=2057019, encodeId=58ef205e019ad, content=<a href='/topic/show?id=a19b1e4042f' target=_blank style='color:#2F92EE;'>#THORAC#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=51, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=17404, encryptionId=a19b1e4042f, topicName=THORAC)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=052a130, createdName=yyj062, createdTime=Tue Jul 24 11:25:00 CST 2018, time=2018-07-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1666174, encodeId=7cb116661e404, content=<a href='/topic/show?id=5fd55943ecf' target=_blank style='color:#2F92EE;'>#早期肺癌#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=62, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=59437, encryptionId=5fd55943ecf, topicName=早期肺癌)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=592126038749, createdName=循证小兵, createdTime=Tue Apr 17 02:25:00 CST 2018, time=2018-04-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=293253, encodeId=03a0293253a7, content=同意比调查研究!受益匪浅!, beContent=null, objectType=article, channel=null, level=null, likeNumber=95, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2017/11/18/11084326017c92749e11fafe7cafb4fe.jpg, createdBy=aa662063559, createdName=1341ee7725m, createdTime=Mon Mar 05 14:51:16 CST 2018, time=2018-03-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=292121, encodeId=ea0729212155, content=好知识.值得学习, beContent=null, objectType=article, channel=null, level=null, likeNumber=100, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=59321624668, createdName=zb1235672, createdTime=Fri Mar 02 01:19:33 CST 2018, time=2018-03-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=291832, encodeId=9c29291832b7, content=好知识值得学习, beContent=null, objectType=article, channel=null, level=null, likeNumber=83, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=59321624668, createdName=zb1235672, createdTime=Thu Mar 01 01:45:21 CST 2018, time=2018-03-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=291501, encodeId=222e2915012f, content=好知识.值得学习, beContent=null, objectType=article, channel=null, level=null, likeNumber=68, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=59321624668, createdName=zb1235672, createdTime=Wed Feb 28 00:09:14 CST 2018, time=2018-02-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=290924, encodeId=26a2290924b7, content=好知识.值得学习, beContent=null, objectType=article, channel=null, level=null, likeNumber=85, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=59321624668, createdName=zb1235672, createdTime=Mon Feb 26 00:49:04 CST 2018, time=2018-02-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=290621, encodeId=21fe2906218b, content=好知识!值得学习, beContent=null, objectType=article, channel=null, level=null, likeNumber=48, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=59321624668, createdName=zb1235672, createdTime=Sun Feb 25 00:03:28 CST 2018, time=2018-02-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=290447, encodeId=4e1129044e10, content=好知识.值得学习, beContent=null, objectType=article, channel=null, level=null, likeNumber=53, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=59321624668, createdName=zb1235672, createdTime=Sat Feb 24 08:36:01 CST 2018, time=2018-02-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=290206, encodeId=833a29020692, content=好知识.值得学习, beContent=null, objectType=article, channel=null, level=null, likeNumber=53, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=59321624668, createdName=zb1235672, createdTime=Fri Feb 23 10:21:37 CST 2018, time=2018-02-23, status=1, ipAttribution=)]
    2018-02-24 zb1235672

    好知识.值得学习

    0

  10. [GetPortalCommentsPageByObjectIdResponse(id=2057019, encodeId=58ef205e019ad, content=<a href='/topic/show?id=a19b1e4042f' target=_blank style='color:#2F92EE;'>#THORAC#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=51, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=17404, encryptionId=a19b1e4042f, topicName=THORAC)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=052a130, createdName=yyj062, createdTime=Tue Jul 24 11:25:00 CST 2018, time=2018-07-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1666174, encodeId=7cb116661e404, content=<a href='/topic/show?id=5fd55943ecf' target=_blank style='color:#2F92EE;'>#早期肺癌#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=62, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=59437, encryptionId=5fd55943ecf, topicName=早期肺癌)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=592126038749, createdName=循证小兵, createdTime=Tue Apr 17 02:25:00 CST 2018, time=2018-04-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=293253, encodeId=03a0293253a7, content=同意比调查研究!受益匪浅!, beContent=null, objectType=article, channel=null, level=null, likeNumber=95, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2017/11/18/11084326017c92749e11fafe7cafb4fe.jpg, createdBy=aa662063559, createdName=1341ee7725m, createdTime=Mon Mar 05 14:51:16 CST 2018, time=2018-03-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=292121, encodeId=ea0729212155, content=好知识.值得学习, beContent=null, objectType=article, channel=null, level=null, likeNumber=100, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=59321624668, createdName=zb1235672, createdTime=Fri Mar 02 01:19:33 CST 2018, time=2018-03-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=291832, encodeId=9c29291832b7, content=好知识值得学习, beContent=null, objectType=article, channel=null, level=null, likeNumber=83, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=59321624668, createdName=zb1235672, createdTime=Thu Mar 01 01:45:21 CST 2018, time=2018-03-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=291501, encodeId=222e2915012f, content=好知识.值得学习, beContent=null, objectType=article, channel=null, level=null, likeNumber=68, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=59321624668, createdName=zb1235672, createdTime=Wed Feb 28 00:09:14 CST 2018, time=2018-02-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=290924, encodeId=26a2290924b7, content=好知识.值得学习, beContent=null, objectType=article, channel=null, level=null, likeNumber=85, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=59321624668, createdName=zb1235672, createdTime=Mon Feb 26 00:49:04 CST 2018, time=2018-02-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=290621, encodeId=21fe2906218b, content=好知识!值得学习, beContent=null, objectType=article, channel=null, level=null, likeNumber=48, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=59321624668, createdName=zb1235672, createdTime=Sun Feb 25 00:03:28 CST 2018, time=2018-02-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=290447, encodeId=4e1129044e10, content=好知识.值得学习, beContent=null, objectType=article, channel=null, level=null, likeNumber=53, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=59321624668, createdName=zb1235672, createdTime=Sat Feb 24 08:36:01 CST 2018, time=2018-02-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=290206, encodeId=833a29020692, content=好知识.值得学习, beContent=null, objectType=article, channel=null, level=null, likeNumber=53, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=59321624668, createdName=zb1235672, createdTime=Fri Feb 23 10:21:37 CST 2018, time=2018-02-23, status=1, ipAttribution=)]
    2018-02-23 zb1235672

    好知识.值得学习

    0

相关资讯

PNAS:血检可发现早期肺癌

  英国一项最新研究显示,通过简单的血液检测就可以发现早期肺癌迹象,这能够让病人避免传统的侵入式检查所带来的不便。研究报告发表在10月16日的美国《国家科学院学报》上。   英国约克大学等机构的研究人员报告说,他们发现Ciz1 蛋白质的一种变体存在于肺癌肿瘤中,即便是非常早期的肿瘤,也存在这种蛋白质的变体。   研究人员道恩·科弗利说,这种蛋白质的变体可以通过某种方式进入血液,并会在

陈海泉教授:越来越多肺小结节被发现后的应对策略

随着早期肺癌早诊早筛的开展,早期肺癌特别是小结节的比例在不断增加,到底哪部分患者需要做早期筛查?对手术方式又有何影响?小编有幸邀请到来自复旦大学附属肿瘤医院的陈海泉教授为大家解答一系列问题。

胡坚教授:早期肺癌筛查的重要性

随着早期肺癌早诊早筛的开展,早期肺癌特别是小结节被发现的比例在增加,那么到底哪部分患者需要做早期筛查?对手术方式又有何影响?肿瘤资讯有幸邀请到浙江大学附属第一医院胸外科胡坚教授为大家解答一系列问题。

Cell:早期肺癌怎么治?

根据今天在Cell发表的新的西奈山研究报告,在晚期肺癌患者中取得显着效果的免疫治疗也可能对新诊断的患者抱有很大的希望,有机会抓住并提供潜在的治疗方法,切断致命的疾病。

ISRD & ATS 2016:白冲教授谈早期肺癌的全程管理

2016 年10月14日~16日,由上海梅斯医学承办的“第十二届上海国际呼吸学会暨ATS联合论坛”(ISRD & ATS 2016)在上海展览中心隆重举行。16日下午,在肺癌专场,来自第二军医大学长海医院呼吸与危重症医学科的白冲教授给我们分享了早期肺癌的全程管理方面的经验。下面是梅斯小编整理的现场精彩报告。

N Engl J Med:TRACERx研究揭秘ctDNA系统进化:早期肺癌如何演变?

诸多研究表明肿瘤异质性是导致晚期肿瘤发生耐药、进展的始作俑者。迫于系统性治疗药物的选择压力,肿瘤细胞不断发生基因突变而分化为不同的亚克隆群体。那么,考虑到其形态和基因异质性均较高,早期肺癌的动态血ctDNA会有怎样的基因改变来驱动肿瘤进化以暗度陈仓呢?近期,英国Charles Swanton教授在Nature发表了TRACERx研究(TRAcking non-small cell lung Can

Baidu
map
Baidu
map
Baidu
map